BiotechTube

TN-TC11G + Temozolomide Oral Product

Phase 1/2Completed
0 watching 0 views this week💤 Quiet
36
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Glioblastoma

Conditions

Glioblastoma

Trial Timeline

Aug 18, 2023 → Nov 13, 2025

NCT ID
NCT03529448

About TN-TC11G + Temozolomide Oral Product

TN-TC11G + Temozolomide Oral Product is a phase 1/2 stage product being developed by Tilray for Glioblastoma. The current trial status is completed. This product is registered under clinical trial identifier NCT03529448. Target conditions include Glioblastoma.

Hype Score Breakdown

Clinical
13
Activity
8
Company
5
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT03529448Phase 1/2Completed

Competing Products

20 competing products in Glioblastoma

See all competitors
ProductCompanyStageHype Score
TemferonGenenta SciencePhase 1/2
33
PLX3397 + TemozolomideDaiichi SankyoPhase 1/2
41
PLX3397Daiichi SankyoPhase 2
52
ASP8374 + cemiplimabAstellas PharmaPhase 1
33
Nimotuzumab + TemozolomideSun PharmaceuticalPhase 2
52
Gliadel + Avastin + TemodarEisaiPhase 2
52
BCNU Wafer + Irinotecan + BevacizumabEisaiPhase 1/2
41
KHK2455Kyowa KirinPre-clinical
23
olaratumab + ramucirumabEli LillyPhase 2
52
enzastaurin + temozolomideEli LillyPhase 1/2
41
enzastaurin + bevacizumab + Enzyme-inducing antiepileptic drugs (EIAED) + Non-enzyme inducing antiepileptic drugs (NEIAED)Eli LillyPhase 2
52
Temozolomide + Neratinib + QBS10072S + Abemaciclib + CC-115Eli LillyPhase 2
52
AbemaciclibEli LillyPhase 2
52
Enzastaurin 500 milligram (mg) Once Daily (QD) + Enzastaurin 250 mg Twice Daily (BID)Eli LillyPhase 2
52
Abemaciclib + LY3214996Eli LillyPhase 1
33
enzastaurin + lomustineEli LillyPhase 3
77
Galunisertib + Lomustine + PlaceboEli LillyPhase 2
52
DSP-7888 Dosing Emulsion + BevacizumabSumitomo PharmaPhase 3
77
DSP-7888Sumitomo PharmaPhase 1/2
41
BBI608 + TemozolomideSumitomo PharmaPhase 1/2
41

Other Products from Tilray

Cannabidiol (CBD) Oil Capsules + Sunflower Lecithin Oil in CapsulePhase 3
72
TN-TC11M2 oral capsules (THC 2.5 mg/CBD 2.5 mg) + TN-C200M2 oral capsules (CBD 200 mg)Phase 2
47
High THC/Low CBD Cannabis + High THC/High CBD Cannabis + Low THC/Low CBD CannabisPhase 2
47
Cannabidiol + PlacebosPhase 1/2
36
Phytocannabinoid cannabidiol (CBD)Phase 1/2
36